Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-04-16 Sale | 2024-04-18 4:01 pm | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,402 | $55.55 | $522,260 | 36,806 (Direct) | View |
2024-03-15 Sale | 2024-03-18 6:38 pm | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,000 | $70.4 | $633,582 | 46,208 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-28 Option Award | 2024-06-06 4:18 pm | N/A 2034-05-28 | Arcellx Inc. | ACLX | Ware Olivia C Director | 8,011 | $0 | 8,011 (Direct) | View |
2024-05-24 Option Award | 2024-05-29 5:55 pm | N/A 2034-05-23 | Contineum Therapeutics Inc. | CTNM | Ware Olivia C Director | 3,700 | $0 | 3,700 (Direct) | View |
2024-05-01 Option Award | 2024-05-03 08:47 am | N/A 2034-04-30 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 38,458 | $0 | 55,133 (Direct) | View |
2024-04-16 Exercise | 2024-04-18 4:01 pm | N/A N/A | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,402 | $7.61 | 36,806 (Direct) | View |
2024-04-16 Exercise | 2024-04-18 4:01 pm | N/A 2032-05-16 | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,402 | $0 | 36,806 (Direct) | View |
Ownership | 2024-04-04 5:59 pm | N/A 2034-03-26 | Contineum Therapeutics Inc. | CTNM | Ware Olivia C Director | 0 | $0 | 29,479 (Direct) | View |
2024-03-15 Exercise | 2024-03-18 6:38 pm | N/A N/A | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,000 | $7.61 | 46,208 (Direct) | View |
2024-03-15 Exercise | 2024-03-18 6:38 pm | N/A 2032-05-16 | Arcellx Inc. | ACLX | Ware Olivia C Director | 9,000 | $0 | 46,208 (Direct) | View |
2023-06-14 Option Award | 2023-06-16 4:23 pm | N/A 2033-06-14 | Arcellx Inc. | ACLX | Ware Olivia C Director | 11,459 | $0 | 11,459 (Direct) | View |
2023-05-03 Option Award | 2023-05-05 5:15 pm | N/A 2033-05-02 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 9,449 | $0 | 22,590 (Direct) | View |
2022-05-16 Option Award | 2022-05-17 5:14 pm | N/A 2032-05-16 | Arcellx Inc. | ACLX | Ware Olivia C Director | 55,208 | $0 | 55,208 (Direct) | View |
2022-05-04 Option Award(A) | 2022-05-13 6:16 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 10,756 | $0 | 10,756 (Direct) | View |
2022-05-04 Option Award | 2022-05-06 6:17 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 17,402 | $0 | 24,484 (Direct) | View |
2021-05-05 Option Award | 2021-05-07 7:23 pm | N/A 2031-05-04 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 1,942 | $0 | 8,350 (Direct) | View |
2021-03-08 Option Award | 2021-03-10 7:13 pm | N/A 2031-03-07 | Revance Therapeutics Inc. | RVNC | Ware Olivia C Director | 17,569 | $0 | 17,569 (Direct) | View |